Company Overview

Provectus Biopharmaceuticals, Inc. is a development-stage biopharmaceutical company dedicated to investigating potential therapeutics for cancer and inflammatory dermatoses.

Recent Financial News

Date	Headline
Jul 22, 2020	Provectus Biopharmaceuticals Announces Acceptance of Two PV-10® Melanoma Cancer Abstracts at European Society for Medical Oncology (ESMO) Virtual Congress 2020
Jul 16, 2020	Provectus Biopharmaceuticals Announces Change to Board of Directors
Jun 22, 2020	Provectus Biopharmaceuticals Announces Discovery of Unique PV-10®-Induced STING Pathway Mechanism for Presentation at American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting II
Jun 09, 2020	Provectus Biopharmaceuticals Expands Global Patent Portfolio to India for Cancer Combination Therapy
Jun 01, 2020	Provectus Announces Presentation of Updated Data from Metastatic Uveal Melanoma Cohort of Phase 1 PV-10® Study at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program

Investor Contacts

Our Contact Form	Mailing Address
Telephone: +1 (866) 594-5999 Fax: +1 (866) 998-0005 info@pvct.com	Provectus Biopharmaceuticals, Inc. 10025 Investment Drive, Suite 250 Knoxville, TN 37932
Investor Relations	Media Relations
Provectus Biopharmaceuticals, Inc. Email: investorrelations@pvct.com Phone: +1 (866) 594-5999 x1	Provectus Biopharmaceuticals, Inc. E-mail: mediarelations@pvct.com Phone: +1 (866) 594-5999 x4
Transfer Agent
(i.e. stockholder records, transfer, change of address, etc.) Broadridge Corporate Issuer Solutions, Inc. P.O. Box 1342 Brentwood, NY 11717 E-mail: shareholder@broadridge.com Telephone: +1 (877) 830-4936 Fax: +1 (215) 553-5402

Stock Performance

Today's Open	0.06
Volume	110,543
Day Range	0.06 - 0.08
52 Week Range	0.03 - 0.08
Bid/Ask	0.07 / 0.07
Bid/Ask Size	67,499 X 49,800
Previous Close	0.07
Market Cap	27.86 million
Shares Outstanding	390.69 million
Dividend/Yield	0.00 / 0.00%
EPS (TTM)	-0.02
P/E Ratio (TTM)	N/A

Recent XBRL Filings

Filing Date	Form Type	Description	View
May 13, 2020	10-Q	Quarterly report	html pdf xbrl
Mar 05, 2020	10-K	Annual report	html pdf xbrl
Nov 12, 2019	10-Q	Quarterly report	html pdf xbrl
Aug 08, 2019	10-Q	Quarterly report	html pdf xbrl
May 13, 2019	10-Q	Quarterly report	html pdf xbrl